title: chip#12313874

description:
Experiment Design 1) Experiment Type normal vs diseased comparison, time course 2) Experimental Factor response to viral infection - SHIV89.6P 3) Number of hybridizations 60 4) Common Reference No 5) Quality Control Steps 4 technical replicate hybridizations per animal (3 replicate hybridizations for C89115M, C95067F) dual spotting of gene per array multiple spotting of select genes per array 2 biological replicates (2 different animals) per time point dye swaps 6) Experiment Description 4 cynomolgus monkeys (Macaca fascicularis) were infected with TCID50 of SHIV89.6P. Whole blood RNA was collected at 0, 1, 2, 4 and 5 weeks post-infection. Post-infection samples were competitively hybridized with pre-infected samples for each individual animal. Unpublished Data 7) Qualifier, value, source 2.2. Samples: samples used, extract preparation and labeling 2.2.1. Biosource properties 1) Organism (NCBI taxonomy) Macaca fascicularis 2) Contact details for sample Dr Erling W Rud Animal Resources Division, Health Canada. Sir Frederick Banting Research Centre Building 22, Room C308, postal locator 2203E Tunneys' Pasture Ottawa,Ontario, Canada K1A 0L2 Tel:(613) 957-8049 FAX:(613) 941-6625 erling_rud@hc-sc.gc.ca 3) Cell Type not applicable 4) Sex C88015F - female C89115M - male C94071M - male C95067F - female 5) Age C88015F - 13 years C89115M - 12 years C94071M - 7 years C95067F - 6 years 6) Developmental Stage adult 7) Organism Part peripheral whole blood 8) Strain or line not applicable 9) Genetic variation not applicable 10) Individual number C88015F, C89115M, C94071M & C95067F 11) Individual genetic characteristics not applicable 12) Disease state normal, AIDS 13) Targeted cell type blood 14) Cell line not applicable 2.2.2. Biomaterial manipulation 1) Growth conditions not applicable 2) In vivo treatments description - 4 cynomolgus monkeys (Macaca fascicularis) were infected intravenously with TCID50 of SHIV89.6P. 10 ml of peripheral blood was drawn at -2, 0, 1, 2, 4 and 5 weeks post-infection. 3) In vitro treatment not applicable 4) Treatment type infection 5) Compound not applicable 6) Separation technique not applicable 2.2.3. Hybridization extract preparation 1) Extraction method PAXgene peripheral blood RNA preparation 10 ml of peripheral blood was drawn from each animal directly into 4 PAXgene Blood RNA Tubes (QIAGEN #762125) according to manufacturer's protocol (http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/PaxgeneBloodRNAtube.pdf) Total RNA was purified using PAXgene Blood RNA kit (QIAGEN # 762134) according to manufacturer's protocol http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/1017455PAXgeneBloodRNA_prot.pdf) 2) Nucleic acid type total RNA 3) Amplification Method Total RNA was amplified using the Ambion MessageAmp aRNA kit (#1750), an Eberwine based method, with slight modifications to the manufacturer's protocol (http://www.transnet.ca/Amplification%20Protocol.htm). 2.2.3. Sample labeling 1) Amount of nucleic acid labeled 6 micrograms of aRNA was labeled with Cy3/Cy5 for hybridization 2) Label used Cy5 & Cy3 3) Label incorporation method aRNA was labelled by reverse transcription using the standard protocol of the Ontario Cancer Institute with slight modifications (http://www.transnet.ca/Hybridization%20Protocol_2.htm) 2.2.5. Spiking controls 1) Spiking control feature OCI Human 19k3-part1 OCI Human 19k3-part2 2) Spike type and qualifier not applicable 3) Qualifier, value, source not applicable 2.3. Hybridization procedure and parameters 2) Hybridization Protocol Protocol - (http://www.transnet.ca/Hybridization%20Protocol_2.htm) Solution Hybridization buffer: DIG solution (Roche cat.#1603558) supplemented with 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA Blocking agent not applicable Slide blocking not applicable Probe blocking: 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA during hybridization Wash procedure 3x15 min with 1xSSC, 0.1% SDS at 50 degrees Celsius, 3 fast washes in 1xSSC at 50 degrees Celsius Quantity of labelled target used all material generated from 6 ug amplified RNA per sample Time 18 hr (overnight) hybridization Concentration 0.2 ug/ul of aRNA per hybridization Volume 60 ul Temperature 30 degrees Celsius Description of the hybridization chamber hybridizations were incubated in a microscope slide box stored within a tissue culture incubator Qualifier, value, source not applicable 2.4. Measurements 2.4.1. Raw data Scanning protocol Scanning hardware: Scanarray Express Microarray Scanner, Packard Biosciences Scanning software: Scanarray Express Microarray Analysis System v1.1 Build #9 Scan Parameters Laser power: see individual image files in section 2.4.1 Spatial resolution:10 microns PMT gain: 60% 2.4.2. Image analysis and quantitation Image analysis software: Quantarray v.3.0, Packard BioSciences Availability: No longer commercially available Quantitation Parameters: Array Pattern: Spot rows: 25 Spot columns: 24 Spot spacing (vertical): 170 microns Spot spacing (horizontal): 170 microns Interstitial spacing: Off Array rows: 8 Array columns: 4 Array spacing (vertical): 4500 microns Array spacing (horizontal): 4500 microns Auto-adjustable Grid: Grid elasticity: 50/100 Spot elasticity: 50/100 Quantitation: Method: Fixed Circle Crosstalk correction: No Normalized to brightest: No Background subtraction: No Gene database file: for OCI Human 19k3-part1- H19k3a.qa (attached) for OCI Human 19k3-part2- H19k3b.qa (attached) Fixed circle quantitation parameters: Spot diameter: 60 microns Inner background diameter: 180 microns Outer background diameter: 200 microns Signal low percentile: 45 Signal high percentile: 95 Background low percentile: 5 Background high percentile: 55 Quantification output: Mean Intensity Quality Criteria Confidence calculation: Minimum Tolerance and weight: None selected Replicates: Combine replicates: no 2.4.3. Normalized and summarized data Data processing protocol Background subtraction and normalization Background subtraction and normalization was performed using the Quantarray Normalization Excel macro on individual quantitation output files. Each channel was background subtracted using the equation: ch Bkg. Subtr. Intensity = ch intensity - ch Bkg. Normalization strategy: total array Normalization algorithm: log ratio median centering Median log ratio = median(log2(ch1 Bkg. Subtr. Intensity) - log2(ch2 Bkg. Subtr. Intensity)) Normalization factor = 2^ median log ratio Normalized ch2 intensity = ch2 intensity*Normalization factor Statistical Analysis The background subtracted normalized intensities were used for statistical analysis. All spot intensities for within-chip, repeat hybridization, fluor-flip hybridization and biological replicates for each time point post-infection were compiled and tested for significance testing using the software package ArrayStat v.1.0, Imaging Research. ArrayStat parameters: Model selection: Manual Model selected: Proportional model with offsets Outlier detection: yes Threshold detection: Manual Threshold detected: p<0.01 Minimum No. of replicates: 12 (for 1 & 5 wks PI), 11 (for 2 & 4 wks PI) Conditions: Dependent Random Error Estimation Method: Small Sample Test: t-test Normalization: By median Nominal alpha: 0.05 Multiple Test correction: False Discovery Rate
Keywords = SHIV89.6P
Keywords = HIV
Keywords = nonhuman primate
Keywords = cDNA microarray
Keywords = time course
Lot batch = Array lot 450


title: chip1243922

status: Public on Nov 03 2004

type: RNA

city: Toronto

first: Steven

middle: Edward

last: Bosinger

state: Ontario

address: 200 Elizabeth St.

department: Division of Experimental Therapeutics

country: Canada

institute: Toronto General Research Institute, University Health Network

description:
Experiment Design 1) Experiment Type normal vs diseased comparison, time course 2) Experimental Factor response to viral infection - SHIV89.6P 3) Number of hybridizations 60 4) Common Reference No 5) Quality Control Steps 4 technical replicate hybridizations per animal (3 replicate hybridizations for C89115M, C95067F) dual spotting of gene per array multiple spotting of select genes per array 2 biological replicates (2 different animals) per time point dye swaps 6) Experiment Description 4 cynomolgus monkeys (Macaca fascicularis) were infected with TCID50 of SHIV89.6P. Whole blood RNA was collected at 0, 1, 2, 4 and 5 weeks post-infection. Post-infection samples were competitively hybridized with pre-infected samples for each individual animal. Unpublished Data 7) Qualifier, value, source 2.2. Samples: samples used, extract preparation and labeling 2.2.1. Biosource properties 1) Organism (NCBI taxonomy) Macaca fascicularis 2) Contact details for sample Dr Erling W Rud Animal Resources Division, Health Canada. Sir Frederick Banting Research Centre Building 22, Room C308, postal locator 2203E Tunneys' Pasture Ottawa,Ontario, Canada K1A 0L2 Tel:(613) 957-8049 FAX:(613) 941-6625 erling_rud@hc-sc.gc.ca 3) Cell Type not applicable 4) Sex C88015F - female C89115M - male C94071M - male C95067F - female 5) Age C88015F - 13 years C89115M - 12 years C94071M - 7 years C95067F - 6 years 6) Developmental Stage adult 7) Organism Part peripheral whole blood 8) Strain or line not applicable 9) Genetic variation not applicable 10) Individual number C88015F, C89115M, C94071M & C95067F 11) Individual genetic characteristics not applicable 12) Disease state normal, AIDS 13) Targeted cell type blood 14) Cell line not applicable 2.2.2. Biomaterial manipulation 1) Growth conditions not applicable 2) In vivo treatments description - 4 cynomolgus monkeys (Macaca fascicularis) were infected intravenously with TCID50 of SHIV89.6P. 10 ml of peripheral blood was drawn at -2, 0, 1, 2, 4 and 5 weeks post-infection. 3) In vitro treatment not applicable 4) Treatment type infection 5) Compound not applicable 6) Separation technique not applicable 2.2.3. Hybridization extract preparation 1) Extraction method PAXgene peripheral blood RNA preparation 10 ml of peripheral blood was drawn from each animal directly into 4 PAXgene Blood RNA Tubes (QIAGEN #762125) according to manufacturer's protocol (http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/PaxgeneBloodRNAtube.pdf) Total RNA was purified using PAXgene Blood RNA kit (QIAGEN # 762134) according to manufacturer's protocol http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/1017455PAXgeneBloodRNA_prot.pdf) 2) Nucleic acid type total RNA 3) Amplification Method Total RNA was amplified using the Ambion MessageAmp aRNA kit (#1750), an Eberwine based method, with slight modifications to the manufacturer's protocol (http://www.transnet.ca/Amplification%20Protocol.htm). 2.2.3. Sample labeling 1) Amount of nucleic acid labeled 6 micrograms of aRNA was labeled with Cy3/Cy5 for hybridization 2) Label used Cy5 & Cy3 3) Label incorporation method aRNA was labelled by reverse transcription using the standard protocol of the Ontario Cancer Institute with slight modifications (http://www.transnet.ca/Hybridization%20Protocol_2.htm) 2.2.5. Spiking controls 1) Spiking control feature OCI Human 19k3-part1 OCI Human 19k3-part2 2) Spike type and qualifier not applicable 3) Qualifier, value, source not applicable 2.3. Hybridization procedure and parameters 2) Hybridization Protocol Protocol - (http://www.transnet.ca/Hybridization%20Protocol_2.htm) Solution Hybridization buffer: DIG solution (Roche cat.#1603558) supplemented with 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA Blocking agent not applicable Slide blocking not applicable Probe blocking: 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA during hybridization Wash procedure 3x15 min with 1xSSC, 0.1% SDS at 50 degrees Celsius, 3 fast washes in 1xSSC at 50 degrees Celsius Quantity of labelled target used all material generated from 6 ug amplified RNA per sample Time 18 hr (overnight) hybridization Concentration 0.2 ug/ul of aRNA per hybridization Volume 60 ul Temperature 30 degrees Celsius Description of the hybridization chamber hybridizations were incubated in a microscope slide box stored within a tissue culture incubator Qualifier, value, source not applicable 2.4. Measurements 2.4.1. Raw data Scanning protocol Scanning hardware: Scanarray Express Microarray Scanner, Packard Biosciences Scanning software: Scanarray Express Microarray Analysis System v1.1 Build #9 Scan Parameters Laser power: see individual image files in section 2.4.1 Spatial resolution:10 microns PMT gain: 60% 2.4.2. Image analysis and quantitation Image analysis software: Quantarray v.3.0, Packard BioSciences Availability: No longer commercially available Quantitation Parameters: Array Pattern: Spot rows: 25 Spot columns: 24 Spot spacing (vertical): 170 microns Spot spacing (horizontal): 170 microns Interstitial spacing: Off Array rows: 8 Array columns: 4 Array spacing (vertical): 4500 microns Array spacing (horizontal): 4500 microns Auto-adjustable Grid: Grid elasticity: 50/100 Spot elasticity: 50/100 Quantitation: Method: Fixed Circle Crosstalk correction: No Normalized to brightest: No Background subtraction: No Gene database file: for OCI Human 19k3-part1- H19k3a.qa (attached) for OCI Human 19k3-part2- H19k3b.qa (attached) Fixed circle quantitation parameters: Spot diameter: 60 microns Inner background diameter: 180 microns Outer background diameter: 200 microns Signal low percentile: 45 Signal high percentile: 95 Background low percentile: 5 Background high percentile: 55 Quantification output: Mean Intensity Quality Criteria Confidence calculation: Minimum Tolerance and weight: None selected Replicates: Combine replicates: no 2.4.3. Normalized and summarized data Data processing protocol Background subtraction and normalization Background subtraction and normalization was performed using the Quantarray Normalization Excel macro on individual quantitation output files. Each channel was background subtracted using the equation: ch Bkg. Subtr. Intensity = ch intensity - ch Bkg. Normalization strategy: total array Normalization algorithm: log ratio median centering Median log ratio = median(log2(ch1 Bkg. Subtr. Intensity) - log2(ch2 Bkg. Subtr. Intensity)) Normalization factor = 2^ median log ratio Normalized ch2 intensity = ch2 intensity*Normalization factor Statistical Analysis The background subtracted normalized intensities were used for statistical analysis. All spot intensities for within-chip, repeat hybridization, fluor-flip hybridization and biological replicates for each time point post-infection were compiled and tested for significance testing using the software package ArrayStat v.1.0, Imaging Research. ArrayStat parameters: Model selection: Manual Model selected: Proportional model with offsets Outlier detection: yes Threshold detection: Manual Threshold detected: p<0.01 Minimum No. of replicates: 12 (for 1 & 5 wks PI), 11 (for 2 & 4 wks PI) Conditions: Dependent Random Error Estimation Method: Small Sample Test: t-test Normalization: By median Nominal alpha: 0.05 Multiple Test correction: False Discovery Rate
Keywords = SHIV89.6P
Keywords = HIV
Keywords = nonhuman primate
Keywords = cDNA microarray
Keywords = time course
Lot batch = Array lot 399

molecule: total RNA

organism: Macaca fascicularis

source_name: monkey C89115M pre-infected

source_name: monkey C89115M 1 wk post SHIV89.6P infection


title: chip#12243930

description:
Experiment Design 1) Experiment Type normal vs diseased comparison, time course 2) Experimental Factor response to viral infection - SHIV89.6P 3) Number of hybridizations 60 4) Common Reference No 5) Quality Control Steps 4 technical replicate hybridizations per animal (3 replicate hybridizations for C89115M, C95067F) dual spotting of gene per array multiple spotting of select genes per array 2 biological replicates (2 different animals) per time point dye swaps 6) Experiment Description 4 cynomolgus monkeys (Macaca fascicularis) were infected with TCID50 of SHIV89.6P. Whole blood RNA was collected at 0, 1, 2, 4 and 5 weeks post-infection. Post-infection samples were competitively hybridized with pre-infected samples for each individual animal. Unpublished Data 7) Qualifier, value, source 2.2. Samples: samples used, extract preparation and labeling 2.2.1. Biosource properties 1) Organism (NCBI taxonomy) Macaca fascicularis 2) Contact details for sample Dr Erling W Rud Animal Resources Division, Health Canada. Sir Frederick Banting Research Centre Building 22, Room C308, postal locator 2203E Tunneys' Pasture Ottawa,Ontario, Canada K1A 0L2 Tel:(613) 957-8049 FAX:(613) 941-6625 erling_rud@hc-sc.gc.ca 3) Cell Type not applicable 4) Sex C88015F - female C89115M - male C94071M - male C95067F - female 5) Age C88015F - 13 years C89115M - 12 years C94071M - 7 years C95067F - 6 years 6) Developmental Stage adult 7) Organism Part peripheral whole blood 8) Strain or line not applicable 9) Genetic variation not applicable 10) Individual number C88015F, C89115M, C94071M & C95067F 11) Individual genetic characteristics not applicable 12) Disease state normal, AIDS 13) Targeted cell type blood 14) Cell line not applicable 2.2.2. Biomaterial manipulation 1) Growth conditions not applicable 2) In vivo treatments description - 4 cynomolgus monkeys (Macaca fascicularis) were infected intravenously with TCID50 of SHIV89.6P. 10 ml of peripheral blood was drawn at -2, 0, 1, 2, 4 and 5 weeks post-infection. 3) In vitro treatment not applicable 4) Treatment type infection 5) Compound not applicable 6) Separation technique not applicable 2.2.3. Hybridization extract preparation 1) Extraction method PAXgene peripheral blood RNA preparation 10 ml of peripheral blood was drawn from each animal directly into 4 PAXgene Blood RNA Tubes (QIAGEN #762125) according to manufacturer's protocol (http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/PaxgeneBloodRNAtube.pdf) Total RNA was purified using PAXgene Blood RNA kit (QIAGEN # 762134) according to manufacturer's protocol http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/1017455PAXgeneBloodRNA_prot.pdf) 2) Nucleic acid type total RNA 3) Amplification Method Total RNA was amplified using the Ambion MessageAmp aRNA kit (#1750), an Eberwine based method, with slight modifications to the manufacturer's protocol (http://www.transnet.ca/Amplification%20Protocol.htm). 2.2.3. Sample labeling 1) Amount of nucleic acid labeled 6 micrograms of aRNA was labeled with Cy3/Cy5 for hybridization 2) Label used Cy5 & Cy3 3) Label incorporation method aRNA was labelled by reverse transcription using the standard protocol of the Ontario Cancer Institute with slight modifications (http://www.transnet.ca/Hybridization%20Protocol_2.htm) 2.2.5. Spiking controls 1) Spiking control feature OCI Human 19k3-part1 OCI Human 19k3-part2 2) Spike type and qualifier not applicable 3) Qualifier, value, source not applicable 2.3. Hybridization procedure and parameters 2) Hybridization Protocol Protocol - (http://www.transnet.ca/Hybridization%20Protocol_2.htm) Solution Hybridization buffer: DIG solution (Roche cat.#1603558) supplemented with 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA Blocking agent not applicable Slide blocking not applicable Probe blocking: 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA during hybridization Wash procedure 3x15 min with 1xSSC, 0.1% SDS at 50 degrees Celsius, 3 fast washes in 1xSSC at 50 degrees Celsius Quantity of labelled target used all material generated from 6 ug amplified RNA per sample Time 18 hr (overnight) hybridization Concentration 0.2 ug/ul of aRNA per hybridization Volume 60 ul Temperature 30 degrees Celsius Description of the hybridization chamber hybridizations were incubated in a microscope slide box stored within a tissue culture incubator Qualifier, value, source not applicable 2.4. Measurements 2.4.1. Raw data Scanning protocol Scanning hardware: Scanarray Express Microarray Scanner, Packard Biosciences Scanning software: Scanarray Express Microarray Analysis System v1.1 Build #9 Scan Parameters Laser power: see individual image files in section 2.4.1 Spatial resolution:10 microns PMT gain: 60% 2.4.2. Image analysis and quantitation Image analysis software: Quantarray v.3.0, Packard BioSciences Availability: No longer commercially available Quantitation Parameters: Array Pattern: Spot rows: 25 Spot columns: 24 Spot spacing (vertical): 170 microns Spot spacing (horizontal): 170 microns Interstitial spacing: Off Array rows: 8 Array columns: 4 Array spacing (vertical): 4500 microns Array spacing (horizontal): 4500 microns Auto-adjustable Grid: Grid elasticity: 50/100 Spot elasticity: 50/100 Quantitation: Method: Fixed Circle Crosstalk correction: No Normalized to brightest: No Background subtraction: No Gene database file: for OCI Human 19k3-part1- H19k3a.qa (attached) for OCI Human 19k3-part2- H19k3b.qa (attached) Fixed circle quantitation parameters: Spot diameter: 60 microns Inner background diameter: 180 microns Outer background diameter: 200 microns Signal low percentile: 45 Signal high percentile: 95 Background low percentile: 5 Background high percentile: 55 Quantification output: Mean Intensity Quality Criteria Confidence calculation: Minimum Tolerance and weight: None selected Replicates: Combine replicates: no 2.4.3. Normalized and summarized data Data processing protocol Background subtraction and normalization Background subtraction and normalization was performed using the Quantarray Normalization Excel macro on individual quantitation output files. Each channel was background subtracted using the equation: ch Bkg. Subtr. Intensity = ch intensity - ch Bkg. Normalization strategy: total array Normalization algorithm: log ratio median centering Median log ratio = median(log2(ch1 Bkg. Subtr. Intensity) - log2(ch2 Bkg. Subtr. Intensity)) Normalization factor = 2^ median log ratio Normalized ch2 intensity = ch2 intensity*Normalization factor Statistical Analysis The background subtracted normalized intensities were used for statistical analysis. All spot intensities for within-chip, repeat hybridization, fluor-flip hybridization and biological replicates for each time point post-infection were compiled and tested for significance testing using the software package ArrayStat v.1.0, Imaging Research. ArrayStat parameters: Model selection: Manual Model selected: Proportional model with offsets Outlier detection: yes Threshold detection: Manual Threshold detected: p<0.01 Minimum No. of replicates: 12 (for 1 & 5 wks PI), 11 (for 2 & 4 wks PI) Conditions: Dependent Random Error Estimation Method: Small Sample Test: t-test Normalization: By median Nominal alpha: 0.05 Multiple Test correction: False Discovery Rate
Keywords = SHIV89.6P
Keywords = HIV
Keywords = nonhuman primate
Keywords = cDNA microarray
Keywords = time course
Lot batch = Array lot 403

source_name: monkey C95067F pre-infected

source_name: monkey C95067F 5 wks post SHIV89.6P infection


title: chip#12243906

source_name: monkey C94071M pre-infected

source_name: monkey C94071M 1 wk post SHIV89.6P infection


title: chip#12313795

source_name: monkey C94071M 4 wk post SHIV89.6P infection


title: chip#12251244


title: chip#12251181


title: A_Ctrl_2

city: Columbus

first: David

middle: Lawrence

last: Newsom

state: OH

department: Human Cancer Genetics

country: USA

institute: Comprehensive Cancer Center

description:
K562 cell line was mock treated.  RNA was extracted using Trizol plus Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA and included suggested level of Affymetrix RNA spike contols.
Keywords = Human, leukemia, mock treated

organism: Homo sapiens

source_name: K562 cell line


title: A_Ctrl_3


title: A_Kin_3

description:
K562 cell line treated for 24 hours with one micromolar imatinib. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA and included half the standard level of Affymetrix RNA spike in controls.
Keywords = Human, leukemia, mock treated

source_name: K562 Cell line


title: A_Kin_1


title: A_Ctrl_1


title: BPL adrenals, replicate 2

status: Public on Nov 02 2004

city: La Jolla

first: Ryan

last: Friese

state: CA

institute: University of California San Diego

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypotensive mouse strain, BPL ("Blood Pressure Low"). Replicate 2 of 3.

organism: Mus musculus

source_name: adrenal gland


title: WKY adrenals, replicate 2

description: Gene expression was measured in adrenal glands of the Wistar-Kyoto rat (WKY) using Affymetrix RG-U34A GeneChips. Replicate 2 of 3.

organism: Rattus norvegicus


title: B_Kin_2


title: BPL adrenals, replicate 1

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypotensive mouse strain, BPL ("Blood Pressure Low"). Replicate 1 of 3.


title: BPL adrenals, replicate 3

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypotensive mouse strain, BPL ("Blood Pressure Low"). Replicate 3 of 3.


title: WKY adrenals, replicate 3

description: Gene expression was measured in adrenal glands of the Wistar-Kyoto rat (WKY) using Affymetrix RG-U34A GeneChips. Replicate 3 of 3.


title: A_Kin_2


title: SHR adrenals, replicate 2

description: Gene expression was measured in adrenal glands of the Spontaneously Hypertensive Rat (SHR) using Affymetrix RG-U34A GeneChips. Replicate 2 of 3.


title: WKY adrenals, replicate 1

description: Gene expression was measured in adrenal glands of the Wistar-Kyoto rat (WKY) using Affymetrix RG-U34A GeneChips. Replicate 1 of 3.


title: chip#12243917

source_name: monkey C88015F pre-infected

source_name: monkey C88015F 5 wks post SHIV89.6P infection


title: chip#12243927


title: chip#12243916

description:
Experiment Design

1) Experiment Type
normal vs diseased comparison, time course

2) Experimental Factor
response to viral infection - SHIV89.6P

3) Number of hybridizations
60

4) Common Reference
No

5) Quality Control Steps
4 technical replicate hybridizations per animal (3 replicate hybridizations for C89115M, C95067F)
dual spotting of gene per array
multiple spotting of select genes per array
2 biological replicates (2 different animals) per time point
dye swaps

6) Experiment Description
4 cynomolgus monkeys (Macaca fascicularis) were infected with TCID50 of SHIV89.6P.
Whole blood RNA was collected at 0, 1, 2, 4 and 5 weeks post-infection. Post-infection samples
were competitively hybridized with pre-infected samples for each individual animal.

Unpublished Data

7) Qualifier, value, source

2.2. Samples: samples used, extract preparation and labeling

2.2.1. Biosource properties

1) Organism (NCBI taxonomy)
Macaca fascicularis

2) Contact details for sample

Dr Erling W Rud
Animal Resources Division, Health Canada.
Sir Frederick Banting Research Centre
Building 22, Room C308, postal locator 2203E
Tunneys' Pasture
Ottawa,Ontario, Canada
K1A 0L2
Tel:(613) 957-8049
FAX:(613) 941-6625
erling_rud@hc-sc.gc.ca

3) Cell Type
not applicable
4) Sex
C88015F - female
C89115M - male
C94071M - male
C95067F - female

5) Age
C88015F - 13 years
C89115M - 12 years
C94071M -  7 years
C95067F -  6 years

6) Developmental Stage
adult

7) Organism Part
peripheral whole blood

8) Strain or line
not applicable

9) Genetic variation
not applicable

10) Individual number
C88015F, C89115M, C94071M & C95067F

11) Individual genetic characteristics
not applicable

12) Disease state
normal, AIDS

13) Targeted cell type
blood

14) Cell line
not applicable

2.2.2. Biomaterial manipulation

1) Growth conditions
not applicable

2) In vivo treatments
description - 4 cynomolgus monkeys (Macaca fascicularis) were infected intravenously with TCID50 of SHIV89.6P.	10 ml of peripheral blood was drawn at -2, 0, 1, 2, 4 and 5 weeks post-infection.

3) In vitro treatment
not applicable

4) Treatment type
infection

5) Compound
not applicable

6) Separation technique
not applicable

2.2.3. Hybridization extract preparation

1) Extraction method
PAXgene peripheral blood RNA preparation

10 ml of peripheral blood was drawn from each animal directly into 4 PAXgene Blood RNA Tubes (QIAGEN #762125) according to manufacturer's protocol (http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/PaxgeneBloodRNAtube.pdf)
Total RNA was purified using PAXgene Blood RNA kit (QIAGEN # 762134) according to manufacturer's protocol http://www.qiagen.com/literature/Handbooks/PDF/DNA_RNA_isolation_clinical/INT/PAXgene_Blood_RNA/1017455PAXgeneBloodRNA_prot.pdf)

2) Nucleic acid type
total RNA

3) Amplification Method
Total RNA was amplified using the Ambion MessageAmp aRNA kit (#1750), an Eberwine based method, with slight modifications to the manufacturer's
protocol (http://www.transnet.ca/Amplification%20Protocol.htm).

2.2.3. Sample labeling

1) Amount of nucleic acid labeled
6 micrograms of aRNA was labeled with Cy3/Cy5 for hybridization

2) Label used
Cy5 & Cy3

3) Label incorporation method
aRNA was labelled by reverse transcription using the standard protocol of the Ontario Cancer Institute with slight modifications (http://www.transnet.ca/Hybridization%20Protocol_2.htm)

2.2.5. Spiking controls

1) Spiking control feature
OCI Human 19k3-part1
OCI Human 19k3-part2

2) Spike type and qualifier
not applicable

3) Qualifier, value, source
not applicable

2.3. Hybridization procedure and parameters

2) Hybridization Protocol

Protocol - (http://www.transnet.ca/Hybridization%20Protocol_2.htm)

Solution
Hybridization buffer:
DIG solution (Roche cat.#1603558) supplemented with 0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA

Blocking agent
not applicable

Slide blocking
not applicable

Probe blocking:
0.45 ug/ul yeast tRNA, 0.45 ug/ul salmon sperm DNA during hybridization

Wash procedure
3x15 min with 1xSSC, 0.1% SDS at 50 degrees Celsius, 3 fast washes in 1xSSC at 50 degrees Celsius

Quantity of labelled target used
all material generated from 6 ug amplified RNA per sample

Time
18 hr (overnight) hybridization

Concentration
0.2 ug/ul of aRNA per hybridization

Volume
60 ul

Temperature
30 degrees Celsius

Description of the hybridization chamber
hybridizations were incubated in a microscope slide box stored within a tissue culture incubator

Qualifier, value, source
not applicable

2.4. Measurements

2.4.1. Raw data

Scanning protocol

Scanning hardware:
Scanarray Express Microarray Scanner, Packard Biosciences

Scanning software:
Scanarray Express Microarray Analysis System v1.1 Build #9

Scan Parameters
Laser power: see individual image files in section 2.4.1
Spatial resolution:10 microns
PMT gain: 60%

2.4.2. Image analysis and quantitation

Image analysis software: Quantarray v.3.0, Packard BioSciences

Availability: No longer commercially available

Quantitation Parameters:
Array Pattern:
Spot rows: 25
Spot columns: 24
Spot spacing (vertical): 170 microns
Spot spacing (horizontal): 170 microns
Interstitial spacing: Off
Array rows: 8
Array columns: 4
Array spacing (vertical): 4500 microns
Array spacing (horizontal): 4500 microns
Auto-adjustable Grid:
Grid elasticity: 50/100
Spot elasticity: 50/100
Quantitation:
Method: Fixed Circle
Crosstalk correction: No
Normalized to brightest: No
Background subtraction: No
Gene database file:	for OCI Human 19k3-part1- H19k3a.qa (attached)
for OCI Human 19k3-part2- H19k3b.qa (attached)
Fixed circle quantitation parameters:
Spot diameter: 60 microns
Inner background diameter: 180 microns
Outer background diameter: 200 microns
Signal low percentile: 45
Signal high percentile: 95
Background low percentile: 5
Background high percentile: 55
Quantification output: Mean Intensity
Quality Criteria
Confidence calculation: Minimum
Tolerance and weight: None selected
Replicates:
Combine replicates: no

2.4.3. Normalized and summarized data

Data processing protocol

Background subtraction and normalization
Background subtraction and normalization was performed using the
Quantarray Normalization Excel macro on individual quantitation output files. Each channel was background subtracted using the equation:

ch Bkg. Subtr. Intensity = ch intensity - ch Bkg.

Normalization strategy: total array

Normalization algorithm: log ratio median centering

Median log ratio = median(log2(ch1 Bkg. Subtr. Intensity) - log2(ch2 Bkg. Subtr. Intensity))

Normalization factor = 2^ median log ratio

Normalized ch2 intensity = ch2 intensity*Normalization factor

Statistical Analysis
The background subtracted normalized intensities were used for statistical analysis. All spot intensities for within-chip, repeat hybridization, fluor-flip hybridization and biological replicates for each time point post-infection were compiled and tested for significance testing using the software package ArrayStat v.1.0, Imaging Research.

ArrayStat parameters:
Model selection: Manual
Model selected: Proportional model with offsets
Outlier detection: yes
Threshold detection: Manual
Threshold detected: p<0.01
Minimum No. of replicates: 12 (for 1 & 5 wks PI), 11 (for 2 & 4 wks PI)
Conditions: Dependent
Random Error Estimation Method: Small Sample
Test: t-test
Normalization: By median
Nominal alpha: 0.05
Multiple Test correction: False Discovery Rate

Keywords = SHIV89.6P
Keywords = HIV
Keywords = nonhuman primate
Keywords = cDNA microarray
Keywords = time course
Lot batch = Array lot 399


title: SHR adrenals, replicate 3

description: Gene expression was measured in adrenal glands of the Spontaneously Hypertensive Rat (SHR) using Affymetrix RG-U34A GeneChips. Replicate 3 of 3.


title: chip#12313879

source_name: monkey C89115M 4 wk post SHIV89.6P infection


title: SHR adrenals, replicate 1

description: Gene expression was measured in adrenal glands of the Spontaneously Hypertensive Rat (SHR) using Affymetrix RG-U34A GeneChips. Replicate 1 of 3.


title: BPH adrenals, replicate 3

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypertensive mouse strain, BPH ("Blood Pressure High"). Replicate 3 of 3.


title: ArrayE: control response

status: Public on Nov 01 2004

city: Bilthoven

first: Jeroen

last: Pennings

address: A. van Leeuwenhoeklaan 9

country: Netherlands

institute: Natl. Inst. Public Health & Environment

description:
Lung RNA was isolated after no intratracheal instillation. Equal amounts of RNA isolated from three rats were pooled and used for hybridisation.
Keywords = particulate matter

source_name: Lung


title: ArrayB: intermediate response

description:
Lung RNA was isolated after EHC-93 exposure by intratracheal instillation. Equal amounts of RNA isolated after 15,18,21 hours were pooled and used for hybridisation.
Keywords = particulate matter


title: ArrayC: late response

description:
Lung RNA was isolated after EHC-93 exposure by intratracheal instillation. Equal amounts of RNA isolated after 24,32,40 hours were pooled and used for hybridisation.
Keywords = particulate matter


title: BPH adrenals, replicate 2

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypertensive mouse strain, BPH ("Blood Pressure High"). Replicate 2 of 3.


title: ArrayD: sham exposure response

description:
Lung RNA was isolated after saline intratracheal instillation. Equal amounts of RNA isolated after 2,15,24 hours were pooled and used for hybridisation.
Keywords = particulate matter


title: 09.2.TypeI_1_Day.0.CEL

city: San Francisco

first: Leland

last: Dobbs

institute: UCSF

description:
Total RNA from freshly isolated TI cells
BRL Superscript Choice; ENZO Bio labeling

source_name: isolated TI cells


title: BPH adrenals, replicate 1

description: Affymetrix GeneChip experiment performed on mRNA from adrenal glands of the hypertensive mouse strain, BPH ("Blood Pressure High"). Replicate 1 of 3.


title: 10.3.TypeI_1_Day.0.CEL


title: 07.3.TypeI_2_Day.7.CEL

description:
Total RNA from cultured TII cells
BRL Superscript Choice; ENZO Bio labeling


title: 08.1.TypeI_1_Day.0.CEL


title: 02.2.TypeI_2_Day.0.CEL

description:
Total RNA from freshly isolated TII cells
BRL Superscript Choice; ENZO Bio labeling


title: 03.3.TypeI_2_Day.0.CEL


title: Fig7 hsa-mir23b rep2

city: Philadelphia

first: Don

last: Baldwin

state: PA

address: 277 John Morgan, 3620 Hamilton Walk

department: Pathology and Lab Medicine

institute: University of Pennsylvania

description:
Figure 7, A novel method for microarray-based, high-throughput, gene expression profiling of microRNAs. Nature Methods, Nov 2004
Keywords = microRNA

source_name: synthetic


title: 01.1.TypeI_2_Day.0.CEL


title: 04.4.TypeI_2_Day.0.CEL


title: 11.4.TypeI_1_Day.0.CEL


title: ArrayA: early response

description:
Lung RNA was isolated after EHC-93 exposure by intratracheal instillation. Equal amounts of RNA isolated after 2,4,6 hours were pooled and used for hybridisation.
Keywords = particulate matter


title: 05.1.TypeI_2_Day.7.CEL


title: Fig7 hsa-mir200b rep2


title: Fig7 mmu-mir200b rep2


title: Fig7 hsa-mir23a rep1


title: 06.2.TypeI_2_Day.7.CEL


title: Fig7 hsa-mir23a rep2


title: Fig7 hsa-mir27a rep1


title: Fig7 hsa-mir200b rep1


title: Fig5 Jurkat rep3

description:
Figure 5, A novel method for microarray-based, high-throughput, gene expression profiling of microRNAs. Nature Methods, Nov 2004
Keywords = microRNA

source_name: Jurkat cells


title: Fig7 hsa-mir27b rep1


title: Fig5 MM rep2

source_name: malignant meningioma


title: Fig5 MM rep3


title: Fig5 MM rep1


title: Fig5 Jurkat rep1


title: Fig7 hsa-mir27a rep2


title: Fig5 Jurkat rep2


title: Fig5 HeLa rep1

source_name: HeLa cells


title: Fig5 AO FFPE rep2

source_name: anaplastic oligodendroglioma, formalin-fixed paraffin embedded


title: Fig5 AO FFPE rep3


title: Fig5 AO fresh rep3

source_name: anaplastic oligodendroglioma, fresh tissue


title: Fig5 AO fresh rep2


title: Fig5 AO fresh rep1


title: Fig5 HeLa rep2


title: Fig5 HeLa rep3


title: Polysomal RNA of U937 in the presence or absence of PMA stimulation (dye-swap)-2/2

city: Ebetsu

first: Hiroshi

last: Kitamura

address: 582 Midorimachi, Bunkyodai

department: School of Veterinary Medicine

country: Japan

institute: Rakuno Gakuen University

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and  after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye-swap experiment data of GSM30873.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome

source_name: Polysomal RNA from PMA-stimulated U937 cells

source_name: Polysomal RNA from intact U937 cells


title: Polysomal RNA of U937 in the presence or absence of PMA stimulation (dye-swap)-1/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and  after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye swap experiment data of GSM30872.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Cytoplasmic RNA of U937 in the presence or absence of PMA stimulation(dyeswap)-2/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye swap experiment data of GSM30857.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome

source_name: Cytoplasmic RNA from PMA-stimulated U937 cells

source_name: Cytoplasmic RNA from intact U937 cells


title: Polysomal RNA of U937 in the presence or absence of PMA stimulation-1/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Fig5 AO FFPE rep1


title: Fig7 hsa-mir23b rep1


title: Fig7 mmu-mir200b rep1


title: Fig2 zero mir124a rep1

description:
Figure 2, A novel method for microarray-based, high-throughput, gene expression profiling of microRNAs. Nature Methods, Nov 2004
Keywords = microRNA


title: Fig2 10e11 mir124a rep1


title: Fig2 zero mir124a rep2


title: Polysomal RNA of U937 in the presence or absence of PMA stimulation-2/2


title: Fig2 10e11 mir124a rep2


title: Fig2 10e9 mir124a rep2


title: Fig2 10e10 mir124a rep1


title: Polysomal and cytoplasmic RNA from PMA-stimulated U937-2/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye-swap experiment data of GSM30851.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Cytoplasmic RNA of U937 in the presence or absence of PMA stimulation-1/2


title: Fig2 10e9 mir124a rep1


title: Fig2 10e8 mir124a rep1


title: Cytoplasmic RNA of U937 in the presence or absence of PMA stimulation(dyeswap)-1/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye swap experiment data of GSM30854.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Fig2 10e7 mir124a rep1


title: Fig2 10e10 mir124a rep2


title: Fig2 10e8 mir124a rep2


title: Fig2 10e7 mir124a rep2


title: Cytoplasmic and polysomal RNA from PMA-stimulated U937-2/2


title: Polysomal and cytoplasmic RNA from PMA-stimulated U937-1/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).  This is a dye swap experiment data of GSM30850.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Cytoplasmic and polysomal RNA from PMA-stumulated U937-1/2


title: Polysomal and Cytoplasmic RNA from intact U937-1/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).This is a dye-swap experiment of GSM30829.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Cytoplasmic and polysomal RNA from intact U937-1/2

source_name: Cytoplasmic RNA from intact U937

source_name: Polysomal RNA from intact U937


title: Polysomal and Cytoplasmic RNA from intact U937-2/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM). This is a dye swap experiment data of GSM30831.
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome


title: Cytoplasmic and polysomal RNA from intact U937-2/2


title: Tongue

status: Public on Oct 30 2004

first: Mark

last: Robinson

institute: University of Toronto

description: Pool of RNA from Tongue tissue

source_name: Tongue


title: Thymus

description: Pool of RNA from Thymus tissue

source_name: Thymus


title: nck2 hybB

city: Berlin

first: Henning

last: Witt

address: Ihnestrasse 65

department: Hans Lehrach

country: Germany

institute: Max Planck Institute for Molecular Genetics

description: total RNA derived from danio rerio nck2 morpholino

organism: Danio rerio

source_name: danio rerio nck2 morpholino


title: Thyroid

description: Pool of RNA from Thyroid tissue

source_name: Thyroid


title: Tongue surface

description: Pool of RNA from Tongue surface tissue

source_name: Tongue surface


title: Uterus

description: Pool of RNA from Uterus tissue

source_name: Uterus


title: Testis

description: Pool of RNA from Testis tissue

source_name: Testis


title: wt control hybA

description: total RNA derived from danio rerio control morpholino

source_name: danio rerio control morpholino


title: Trachea

description: Pool of RNA from Trachea tissue

source_name: Trachea


title: nck2 hybA


title: Small intestine

description: Pool of RNA from Small intestine tissue

source_name: Small intestine


title: Stomach

description: Pool of RNA from Stomach tissue

source_name: Stomach


title: Teeth

description: Pool of RNA from Teeth tissue

source_name: Teeth


title: Skin

description: Pool of RNA from Skin tissue

source_name: Skin


title: Pancreas

description: Pool of RNA from Pancreas tissue

source_name: Pancreas


title: Striatum

description: Pool of RNA from Striatum tissue

source_name: Striatum


title: Prostate

description: Pool of RNA from Prostate tissue

source_name: Prostate


title: Skeletal Muscle

description: Pool of RNA from Skeletal Muscle tissue

source_name: Skeletal Muscle


title: Placenta 9.5

description: Pool of RNA from Placenta 9.5 tissue

source_name: Placenta 9.5


title: Snout

description: Pool of RNA from Snout tissue

source_name: Snout


title: Salivary

description: Pool of RNA from Salivary tissue

source_name: Salivary


title: Spleen

description: Pool of RNA from Spleen tissue

source_name: Spleen


title: Placenta 12.5

description: Pool of RNA from Placenta 12.5 tissue

source_name: Placenta 12.5


title: wt control hybB


title: Spinal cord

description: Pool of RNA from Spinal cord tissue

source_name: Spinal cord


title: Mandible

description: Pool of RNA from Mandible tissue

source_name: Mandible


title: Fig7 hsa-mir27b rep2

source_name: synthetic


title: Olfactory bulb

description: Pool of RNA from Olfactory bulb tissue

source_name: Olfactory bulb


title: Midbrain

description: Pool of RNA from Midbrain tissue

source_name: Midbrain


title: Mammary gland

description: Pool of RNA from Mammary gland tissue

source_name: Mammary gland


title: Lymph node

description: Pool of RNA from Lymph node tissue

source_name: Lymph node


title: Embryo 9.5

description: Pool of RNA from Embryo 9.5 tissue

source_name: Embryo 9.5


title: Knee

description: Pool of RNA from Knee tissue

source_name: Knee


title: Kidney

description: Pool of RNA from Kidney tissue

source_name: Kidney


title: Femur

description: Pool of RNA from Femur tissue

source_name: Femur


title: Heart

description: Pool of RNA from Heart tissue

source_name: Heart


title: Colon

description: Pool of RNA from Colon tissue

source_name: Colon


title: Cortex

description: Pool of RNA from Cortex tissue

source_name: Cortex


title: Digit

description: Pool of RNA from Digit tissue

source_name: Digit


title: Hindbrain

description: Pool of RNA from Hindbrain tissue

source_name: Hindbrain


title: Embryo 12.5

description: Pool of RNA from Embryo 12.5 tissue

source_name: Embryo 12.5


title: Liver

description: Pool of RNA from Liver tissue

source_name: Liver


title: ES

description: Pool of RNA from ES tissue

source_name: ES


title: Embryo

description: Pool of RNA from Embryo tissue

source_name: Embryo


title: Large intestine

description: Pool of RNA from Large intestine tissue

source_name: Large intestine


title: Brown fat

description: Pool of RNA from Brown fat tissue

source_name: Brown fat


title: Cerebellum

description: Pool of RNA from Cerebellum tissue

source_name: Cerebellum


title: Bone Marrow

description: Pool of RNA from Bone Marrow tissue

source_name: Bone Marrow


title: Calvaria

description: Pool of RNA from Calvaria tissue

source_name: Calvaria


title: Brain

description: Pool of RNA from Brain tissue

source_name: Brain


title: Bladder

description: Pool of RNA from Bladder tissue

source_name: Bladder


title: Aorta

description: Pool of RNA from Aorta tissue

source_name: Aorta


title: Epididymus

description: Pool of RNA from Epididymus tissue

source_name: Epididymus


title: E10.5 Head

description: Pool of RNA from E10.5 Head tissue

source_name: E10.5 Head


title: Adrenal

description: Pool of RNA from Adrenal tissue

source_name: Adrenal


title: Acox1-25_Cy3

status: Public on Oct 28 2004

city: Bethesda

first: Snorri

middle: S

last: Thorgeirsson

state: MD

address: 37 Convent Dr. # 4146

department: Laboratory of Experimental Carcinogenesis

institute: National Cancer institute/NIH

description:
mAdb experiment ID: 33458
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-25

source_name: Pooled WT Liver


title: Acox1-20_Cy3

description:
mAdb experiment ID: 33449
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-20


title: Acox1-24_Cy3

description:
mAdb experiment ID: 33457
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p7_111601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-24


title: Acox1-21_Cy3

description:
mAdb experiment ID: 33451
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-21


title: Acox1-23_Cy3

description:
mAdb experiment ID: 33455
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-23


title: Acox1-24_Cy5

description:
mAdb experiment ID: 33456
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-24


title: Acox1-23_Cy5

description:
mAdb experiment ID: 33454
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-23


title: Acox1-20_Cy5

description:
mAdb experiment ID: 33448
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-20


title: Acox1-25_Cy5

description:
mAdb experiment ID: 33459
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-25


title: Acox1-19_Cy3

description:
mAdb experiment ID: 33447
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-19


title: Acox1-22_Cy3

description:
mAdb experiment ID: 33453
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-22


title: Acox1-22_Cy5

description:
mAdb experiment ID: 33452
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-22


title: Acox1-17_Cy5

description:
mAdb experiment ID: 33443
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-17


title: Acox1-18_Cy5

description:
mAdb experiment ID: 33445
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-18


title: Acox1-21_Cy5

description:
mAdb experiment ID: 33450
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-21


title: Acox1-17_Cy3

description:
mAdb experiment ID: 33444
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-17


title: Eye

description: Pool of RNA from Eye tissue

source_name: Eye


title: Acox1-16_Cy3

description:
mAdb experiment ID: 33442
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-16


title: Acox1-16_Cy5

description:
mAdb experiment ID: 33441
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-16


title: Acox1-14_Cy5

description:
mAdb experiment ID: 33437
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-14


title: Acox1-15_Cy5

description:
mAdb experiment ID: 33439
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-15


title: Acox1-15_Cy3

description:
mAdb experiment ID: 33440
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-15


title: Acox1-19_Cy5

description:
mAdb experiment ID: 33446
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-19


title: Acox1-12_Cy5

description:
mAdb experiment ID: 33433
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v4p11_111401
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-12


title: Acox1-13_Cy5

description:
mAdb experiment ID: 33435
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v4p11_111401
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-13


title: Acox1-13_Cy3

description:
mAdb experiment ID: 33436
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p7_111601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-13


title: Acox1-10_Cy5

description:
mAdb experiment ID: 33429
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-10


title: Acox1-11_Cy3

description:
mAdb experiment ID: 33432
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-11


title: Acox1-12_Cy3

description:
mAdb experiment ID: 33434
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v4p11_111401
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-12


title: Acox1-11_Cy5

description:
mAdb experiment ID: 33431
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-11


title: Acox1-08_Cy5

description:
mAdb experiment ID: 33425
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-08


title: Acox1-10_Cy3

description:
mAdb experiment ID: 33430
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-10


title: Acox1-07_Cy5

description:
mAdb experiment ID: 33423
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-07


title: Acox1-07_Cy3

description:
mAdb experiment ID: 33424
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-07


title: Acox1-06_Cy5

description:
mAdb experiment ID: 33421
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-06


title: Acox1-06_Cy3

description:
mAdb experiment ID: 33422
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-06


title: Acox1-09_Cy3

description:
mAdb experiment ID: 33428
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-09


title: Acox1-08_Cy3

description:
mAdb experiment ID: 33426
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-08


title: Acox1-05_Cy3

description:
mAdb experiment ID: 33420
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-05


title: Acox1-05_Cy5

description:
mAdb experiment ID: 33419
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-05


title: Acox1-04_Cy3

description:
mAdb experiment ID: 33418
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-04


title: Lung

description: Pool of RNA from Lung tissue

source_name: Lung


title: Acox1-03_Cy5

description:
mAdb experiment ID: 33415
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-03


title: Trigeminus

description: Pool of RNA from Trigeminus tissue

source_name: Trigeminus


title: Acox1-04_Cy5

description:
mAdb experiment ID: 33417
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-04


title: Acox1-03_Cy3

description:
mAdb experiment ID: 33416
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-03


title: Ovary

description: Pool of RNA from Ovary tissue

source_name: Ovary


title: E14.5 Head

description: Pool of RNA from E14.5 Head tissue

source_name: E14.5 Head


title: Cytoplasmic RNA of U937 in the presence or absence of PMA stimulation-2/2

description:
Human histomonocytic U937 cells exhibit macrophage-like properties after phorbol ester stimulation.  Accumulating evidence demonstrated that remarkable number of transcripts changed in their amount at total RNA levels.  However, post-transcriptional regulation has not been fully elucidated in this model.  Thus, we compared expression profiles between polysomal and cytoplasmic RNAs before and after phorbol 12-myristate 13-acetate stimulation (48h, 32nM).
Keywords = phorbol ester
Keywords = macrophage
Keywords = polysome

source_name: Cytoplasmic RNA from intact U937 cells

source_name: Cytoplasmic RNA from PMA-stimulated U937 cells


title: Acox1-01_Cy5

description:
mAdb experiment ID: 33411
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-01


title: Acox1-02_Cy5

description:
mAdb experiment ID: 33413
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-02


title: Acox1-09_Cy5

description:
mAdb experiment ID: 33427
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-09


title: Acox1-02_Cy3

description:
mAdb experiment ID: 33414
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-02


title: Acox1-01_Cy3

description:
mAdb experiment ID: 33412
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-01


title: HCC090_Cy5

description:
mAdb experiment ID: 42682

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC090
Sample_Description: subgroup A

source_name: Pooled Normal Liver


title: HCC089-2_Cy3

description:
mAdb experiment ID: 42748

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC089-2
Sample_Description: subgroup B


title: HCC090_Cy3

description:
mAdb experiment ID: 42683

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC090
Sample_Description: subgroup A


title: HCC089-1_Cy5

description:
mAdb experiment ID: 42745

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC089-1
Sample_Description: subgroup A


title: HCC088_Cy5

description:
mAdb experiment ID: 42678

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC088
Sample_Description: subgroup A


title: HCC087_Cy5

description:
mAdb experiment ID: 42674

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC087
Sample_Description: subgroup A


title: HCC088_Cy3

description:
mAdb experiment ID: 42679

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC088
Sample_Description: subgroup A


title: HCC086_Cy5

description:
mAdb experiment ID: 42670

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC086
Sample_Description: subgroup B


title: HCC086_Cy3

description:
mAdb experiment ID: 42671

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC086
Sample_Description: subgroup B


title: HCC089-1_Cy3

description:
mAdb experiment ID: 42746

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC089-1
Sample_Description: subgroup A


title: HCC085_Cy5

description:
mAdb experiment ID: 42241

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC085
Sample_Description: subgroup A


title: HCC085_Cy3

description:
mAdb experiment ID: 42242

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC085
Sample_Description: subgroup A


title: HCC087_Cy3

description:
mAdb experiment ID: 42675

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC087
Sample_Description: subgroup A


title: Acox1-14_Cy3

description:
mAdb experiment ID: 33438
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-14


title: HCC084_Cy3

description:
mAdb experiment ID: 42238

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC084
Sample_Description: subgroup A


title: HCC083_Cy5

description:
mAdb experiment ID: 42232

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC083
Sample_Description: subgroup A


title: HCC083_Cy3

description:
mAdb experiment ID: 42233

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC083
Sample_Description: subgroup A


title: HCC082_Cy3

description:
mAdb experiment ID: 42228

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC082
Sample_Description: subgroup B


title: HCC084_Cy5

description:
mAdb experiment ID: 42237

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC084
Sample_Description: subgroup A


title: HCC081_Cy5

description:
mAdb experiment ID: 42222

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC081
Sample_Description: subgroup A


title: HCC081_Cy3

description:
mAdb experiment ID: 42224

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC081
Sample_Description: subgroup A


title: HCC080_Cy3

description:
mAdb experiment ID: 42218

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC080
Sample_Description: subgroup A


title: HCC082_Cy5

description:
mAdb experiment ID: 42227

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC082
Sample_Description: subgroup B


title: HCC078_Cy5

description:
mAdb experiment ID: 50064

Array Print: Hs-OperonV2-vB1.2p1-062503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC078
Sample_Description: subgroup A


title: HCC080_Cy5

description:
mAdb experiment ID: 42217

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC080
Sample_Description: subgroup A


title: HCC079_Cy3

description:
mAdb experiment ID: 42213

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC079
Sample_Description: subgroup A


title: HCC079_Cy5

description:
mAdb experiment ID: 42212

Array Print: Hs-OperonV2-vB1.1p8-041403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC079
Sample_Description: subgroup A


title: HCC078_Cy3

description:
mAdb experiment ID: 50065

Array Print: Hs-OperonV2-vB1.2p1-062503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC078
Sample_Description: subgroup A


title: HCC075_Cy5

description:
mAdb experiment ID: 38939

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC075
Sample_Description: subgroup B


title: HCC076_Cy3

description:
mAdb experiment ID: 41017

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC076
Sample_Description: subgroup A


title: HCC075_Cy3

description:
mAdb experiment ID: 38940

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC075
Sample_Description: subgroup B


title: HCC077_Cy5

description:
mAdb experiment ID: 41020

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC077
Sample_Description: subgroup A


title: HCC076_Cy5

description:
mAdb experiment ID: 41016

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC076
Sample_Description: subgroup A


title: HCC077_Cy3

description:
mAdb experiment ID: 41021

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC077
Sample_Description: subgroup A


title: HCC089-2_Cy5

description:
mAdb experiment ID: 42747

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC089-2
Sample_Description: subgroup B


title: HCC074_Cy5

description:
mAdb experiment ID: 41012

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC074
Sample_Description: subgroup B


title: HCC073_Cy5

description:
mAdb experiment ID: 41008

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC073
Sample_Description: subgroup A


title: Acox1-18_Cy3

description:
mAdb experiment ID: 33474
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-18


title: HCC073_Cy3

description:
mAdb experiment ID: 41009

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC073
Sample_Description: subgroup A


title: HCC072_Cy3

description:
mAdb experiment ID: 41005

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC072
Sample_Description: subgroup A


title: HCC069_Cy3

description:
mAdb experiment ID: 36349

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC069
Sample_Description: subgroup A


title: HCC071_Cy5

description:
mAdb experiment ID: 36353

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC071
Sample_Description: subgroup B


title: HCC070_Cy3

description:
mAdb experiment ID: 41001

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC070
Sample_Description: subgroup A


title: HCC067_Cy3

description:
mAdb experiment ID: 36341

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC067
Sample_Description: subgroup A


title: HCC066_Cy5

description:
mAdb experiment ID: 40996

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC066
Sample_Description: subgroup A


title: HCC071_Cy3

description:
mAdb experiment ID: 36354

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC071
Sample_Description: subgroup B


title: HCC074_Cy3

description:
mAdb experiment ID: 41013

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC074
Sample_Description: subgroup B


title: HCC065_Cy3

description:
mAdb experiment ID: 40993

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC065
Sample_Description: subgroup B


title: HCC067_Cy5

description:
mAdb experiment ID: 36342

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC067
Sample_Description: subgroup A


title: HCC072_Cy5

description:
mAdb experiment ID: 41004

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC072
Sample_Description: subgroup A


title: HCC065_Cy5

description:
mAdb experiment ID: 40992

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC065
Sample_Description: subgroup B


title: HCC069_Cy5

description:
mAdb experiment ID: 36350

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC069
Sample_Description: subgroup A


title: HCC070_Cy5

description:
mAdb experiment ID: 41000

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC070
Sample_Description: subgroup A


title: HCC068_Cy3

description:
mAdb experiment ID: 36345

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC068
Sample_Description: subgroup B


title: HCC064_Cy3

description:
mAdb experiment ID: 40988

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC064
Sample_Description: subgroup A


title: HCC063_Cy5

description:
mAdb experiment ID: 40982

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC063
Sample_Description: subgroup A


title: HCC066_Cy3

description:
mAdb experiment ID: 40997

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC066
Sample_Description: subgroup A


title: HCC062_Cy3

description:
mAdb experiment ID: 39441

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC062
Sample_Description: subgroup A


title: HCC064_Cy5

description:
mAdb experiment ID: 40987

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC064
Sample_Description: subgroup A


title: HCC062_Cy5

description:
mAdb experiment ID: 39440

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC062
Sample_Description: subgroup A


title: HCC063_Cy3

description:
mAdb experiment ID: 40983

Array Print: Hs-OperonV2-vB1.1p5-031303
Tissue_type: Hepatocellular Carcinoma
Sample: HCC063
Sample_Description: subgroup A


title: HCC061_Cy5

description:
mAdb experiment ID: 44414

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC061
Sample_Description: subgroup B


title: HCC061_Cy3

description:
mAdb experiment ID: 44410

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC061
Sample_Description: subgroup B


title: HCC060_Cy5

description:
mAdb experiment ID: 39432

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC060
Sample_Description: subgroup B


title: HCC068_Cy5

description:
mAdb experiment ID: 36346

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC068
Sample_Description: subgroup B


title: HCC060_Cy3

description:
mAdb experiment ID: 39433

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC060
Sample_Description: subgroup B


title: HCC059_Cy5

description:
mAdb experiment ID: 39428

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC059
Sample_Description: subgroup B


title: HCC058_Cy5

description:
mAdb experiment ID: 39424

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC058
Sample_Description: subgroup A


title: HCC057_Cy5

description:
mAdb experiment ID: 39420

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC057
Sample_Description: subgroup A


title: HCC052_Cy3

description:
mAdb experiment ID: 44294

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC052
Sample_Description: subgroup A


title: HCC051_Cy3

description:
mAdb experiment ID: 45230

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC051
Sample_Description: subgroup A


title: HCC048_Cy5

description:
mAdb experiment ID: 36517

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC048
Sample_Description: subgroup B


title: HCC054_Cy3

description:
mAdb experiment ID: 44406

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC054
Sample_Description: subgroup B


title: HCC053_Cy3

description:
mAdb experiment ID: 44297

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC053
Sample_Description: subgroup B


title: HCC047_Cy5

description:
mAdb experiment ID: 36512

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC047
Sample_Description: subgroup B


title: HCC058_Cy3

description:
mAdb experiment ID: 39425

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC058
Sample_Description: subgroup A


title: HCC054_Cy5

description:
mAdb experiment ID: 44405

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC054
Sample_Description: subgroup B


title: HCC052_Cy5

description:
mAdb experiment ID: 44293

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC052
Sample_Description: subgroup A


title: HCC055_Cy3

description:
mAdb experiment ID: 38934

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC055
Sample_Description: subgroup B


title: HCC056_Cy5

description:
mAdb experiment ID: 44408

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC056
Sample_Description: subgroup A


title: HCC053_Cy5

description:
mAdb experiment ID: 44296

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC053
Sample_Description: subgroup B


title: HCC049_Cy5

description:
mAdb experiment ID: 37440

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC049
Sample_Description: subgroup B


title: HCC046_Cy5

description:
mAdb experiment ID: 37003

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC046
Sample_Description: subgroup A


title: HCC055_Cy5

description:
mAdb experiment ID: 38933

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC055
Sample_Description: subgroup B


title: HCC049_Cy3

description:
mAdb experiment ID: 37441

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC049
Sample_Description: subgroup B


title: HCC048_Cy3

description:
mAdb experiment ID: 36518

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC048
Sample_Description: subgroup B


title: HCC045_Cy5

description:
mAdb experiment ID: 37000

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC045
Sample_Description: subgroup B


title: HCC047_Cy3

description:
mAdb experiment ID: 36514

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC047
Sample_Description: subgroup B


title: HCC051_Cy5

description:
mAdb experiment ID: 45229

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC051
Sample_Description: subgroup A


title: HCC050_Cy5

description:
mAdb experiment ID: 38568

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC050
Sample_Description: subgroup B


title: HCC059_Cy3

description:
mAdb experiment ID: 39429

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC059
Sample_Description: subgroup B


title: HCC057_Cy3

description:
mAdb experiment ID: 39421

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC057
Sample_Description: subgroup A


title: HCC046_Cy3

description:
mAdb experiment ID: 37004

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC046
Sample_Description: subgroup A


title: HCC050_Cy3

description:
mAdb experiment ID: 38569

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC050
Sample_Description: subgroup B


title: HCC042_Cy5

description:
mAdb experiment ID: 44356

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC042
Sample_Description: subgroup B


title: HCC039_Cy3

description:
mAdb experiment ID: 45228

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC039
Sample_Description: subgroup A


title: HCC043_Cy3

description:
mAdb experiment ID: 44359

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC043
Sample_Description: subgroup B


title: HCC037_Cy5

description:
mAdb experiment ID: 45223

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC037
Sample_Description: subgroup A


title: HCC036_Cy3

description:
mAdb experiment ID: 45222

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC036
Sample_Description: subgroup A


title: HCC035_Cy5

description:
mAdb experiment ID: 45219

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC035
Sample_Description: subgroup A


title: HCC036_Cy5

description:
mAdb experiment ID: 45221

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC036
Sample_Description: subgroup A


title: HCC035_Cy3

description:
mAdb experiment ID: 45220

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC035
Sample_Description: subgroup A


title: HCC034_Cy3

description:
mAdb experiment ID: 45218

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC034
Sample_Description: subgroup B


title: HCC038_Cy3

description:
mAdb experiment ID: 45226

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC038
Sample_Description: subgroup A


title: HCC037_Cy3

description:
mAdb experiment ID: 45224

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC037
Sample_Description: subgroup A


title: HCC041_Cy5

description:
mAdb experiment ID: 36356

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC041
Sample_Description: subgroup B


title: HCC039_Cy5

description:
mAdb experiment ID: 45227

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC039
Sample_Description: subgroup A


title: HCC042_Cy3

description:
mAdb experiment ID: 44357

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC042
Sample_Description: subgroup B


title: HCC041_Cy3

description:
mAdb experiment ID: 36355

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC041
Sample_Description: subgroup B


title: HCC040_Cy3

description:
mAdb experiment ID: 43402

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC040
Sample_Description: subgroup B


title: HCC033_Cy5

description:
mAdb experiment ID: 45215

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC033
Sample_Description: subgroup B


title: HCC031_Cy5

description:
mAdb experiment ID: 45201

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC031
Sample_Description: subgroup B


title: HCC044_Cy3

description:
mAdb experiment ID: 44361

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC044
Sample_Description: subgroup B


title: HCC040_Cy5

description:
mAdb experiment ID: 43401

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC040
Sample_Description: subgroup B


title: HCC032_Cy3

description:
mAdb experiment ID: 45214

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC032
Sample_Description: subgroup A


title: HCC043_Cy5

description:
mAdb experiment ID: 44358

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC043
Sample_Description: subgroup B


title: HCC034_Cy5

description:
mAdb experiment ID: 45217

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC034
Sample_Description: subgroup B


title: HCC032_Cy5

description:
mAdb experiment ID: 45212

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC032
Sample_Description: subgroup A


title: HCC038_Cy5

description:
mAdb experiment ID: 45225

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC038
Sample_Description: subgroup A


title: HCC044_Cy5

description:
mAdb experiment ID: 44360

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC044
Sample_Description: subgroup B


title: HCC033_Cy3

description:
mAdb experiment ID: 45216

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC033
Sample_Description: subgroup B


title: HCC030_Cy3

description:
mAdb experiment ID: 45200

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC030
Sample_Description: subgroup B


title: HCC025_Cy3

description:
mAdb experiment ID: 37443

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC025
Sample_Description: subgroup B


title: HCC025_Cy5

description:
mAdb experiment ID: 37442

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC025
Sample_Description: subgroup B


title: HCC020_Cy5

description:
mAdb experiment ID: 39314

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC020
Sample_Description: subgroup B


title: HCC028_Cy3

description:
mAdb experiment ID: 36385

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC028
Sample_Description: subgroup B


title: HCC030_Cy5

description:
mAdb experiment ID: 45198

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC030
Sample_Description: subgroup B


title: HCC029_Cy5

description:
mAdb experiment ID: 44166

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC029
Sample_Description: subgroup A


title: HCC024_Cy3

description:
mAdb experiment ID: 38596

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC024
Sample_Description: subgroup B


title: HCC028_Cy5

description:
mAdb experiment ID: 36384

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC028
Sample_Description: subgroup B


title: HCC023_Cy3

description:
mAdb experiment ID: 57665

Array Print: Hs-OperonV2-vB1.3p12-062904
Tissue_type: Hepatocellular Carcinoma
Sample: HCC023
Sample_Description: subgroup A


title: HCC020_Cy3

description:
mAdb experiment ID: 39315

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC020
Sample_Description: subgroup B


title: HCC031_Cy3

description:
mAdb experiment ID: 45213

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC031
Sample_Description: subgroup B


title: HCC021_Cy5

description:
mAdb experiment ID: 37436

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC021
Sample_Description: subgroup B


title: HCC019_Cy5

description:
mAdb experiment ID: 44168

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC019
Sample_Description: subgroup A


title: HCC023_Cy5

description:
mAdb experiment ID: 57664

Array Print: Hs-OperonV2-vB1.3p12-062904
Tissue_type: Hepatocellular Carcinoma
Sample: HCC023
Sample_Description: subgroup A


title: HCC026_Cy3

description:
mAdb experiment ID: 37431

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC026
Sample_Description: subgroup B


title: HCC029_Cy3

description:
mAdb experiment ID: 44167

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC029
Sample_Description: subgroup A


title: HCC021_Cy3

description:
mAdb experiment ID: 37437

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC021
Sample_Description: subgroup B


title: HCC024_Cy5

description:
mAdb experiment ID: 38595

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC024
Sample_Description: subgroup B


title: HCC027_Cy3

description:
mAdb experiment ID: 36453

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC027
Sample_Description: subgroup B


title: HCC022_Cy3

description:
mAdb experiment ID: 44288

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC022
Sample_Description: subgroup B


title: HCC022_Cy5

description:
mAdb experiment ID: 44287

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC022
Sample_Description: subgroup B


title: HCC018_Cy5

description:
mAdb experiment ID: 36340

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC018
Sample_Description: subgroup B


title: HCC027_Cy5

description:
mAdb experiment ID: 36452

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC027
Sample_Description: subgroup B


title: HCC019_Cy3

description:
mAdb experiment ID: 44169

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC019
Sample_Description: subgroup A


title: HCC056_Cy3

description:
mAdb experiment ID: 44409

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC056
Sample_Description: subgroup A


title: HCC045_Cy3

description:
mAdb experiment ID: 37001

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC045
Sample_Description: subgroup B


title: HCC026_Cy5

description:
mAdb experiment ID: 37430

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC026
Sample_Description: subgroup B


title: HCC014_Cy5

description:
mAdb experiment ID: 44084

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC014
Sample_Description: subgroup A


title: HCC017_Cy5

description:
mAdb experiment ID: 36523

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC017
Sample_Description: subgroup B


title: HCC008_Cy3

description:
mAdb experiment ID: 38563

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC008
Sample_Description: subgroup B


title: HCC013_Cy5

description:
mAdb experiment ID: 39304

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC013
Sample_Description: subgroup B


title: HCC018_Cy3

description:
mAdb experiment ID: 36339

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC018
Sample_Description: subgroup B


title: HCC017_Cy3

description:
mAdb experiment ID: 36524

Array Print: Hs-OperonV2-VB1.0p1-103102
Tissue_type: Hepatocellular Carcinoma
Sample: HCC017
Sample_Description: subgroup B


title: HCC007_Cy3

description:
mAdb experiment ID: 44083

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC007
Sample_Description: subgroup B


title: HCC014_Cy3

description:
mAdb experiment ID: 44085

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC014
Sample_Description: subgroup A


title: HCC015_Cy5

description:
mAdb experiment ID: 44284

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC015
Sample_Description: subgroup B


title: HCC005_Cy3

description:
mAdb experiment ID: 44079

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC005
Sample_Description: subgroup B


title: HCC006_Cy3

description:
mAdb experiment ID: 44081

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC006
Sample_Description: subgroup A


title: HCC011_Cy3

description:
mAdb experiment ID: 39299

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC011
Sample_Description: subgroup B


title: HCC011_Cy5

description:
mAdb experiment ID: 39298

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC011
Sample_Description: subgroup B


title: HCC016_Cy3

description:
mAdb experiment ID: 39309

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC016
Sample_Description: subgroup B


title: HCC012_Cy5

description:
mAdb experiment ID: 39302

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC012
Sample_Description: subgroup B


title: HCC005_Cy5

description:
mAdb experiment ID: 44078

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC005
Sample_Description: subgroup B


title: HCC010_Cy5

description:
mAdb experiment ID: 39293

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC010
Sample_Description: subgroup B


title: HCC006_Cy5

description:
mAdb experiment ID: 44080

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC006
Sample_Description: subgroup A


title: HCC015_Cy3

description:
mAdb experiment ID: 44285

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC015
Sample_Description: subgroup B


title: HCC004_Cy3

description:
mAdb experiment ID: 43998

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC004
Sample_Description: subgroup B


title: HCC013_Cy3

description:
mAdb experiment ID: 39305

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC013
Sample_Description: subgroup B


title: HCC004_Cy5

description:
mAdb experiment ID: 43997

Array Print: Hs-OperonV2-vW1.1p10-042903
Tissue_type: Hepatocellular Carcinoma
Sample: HCC004
Sample_Description: subgroup B


title: HCC010_Cy3

description:
mAdb experiment ID: 39294

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC010
Sample_Description: subgroup B


title: HCC009_Cy5

description:
mAdb experiment ID: 38592

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC009
Sample_Description: subgroup B


title: HCC007_Cy5

description:
mAdb experiment ID: 44082

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC007
Sample_Description: subgroup B


title: HCC008_Cy5

description:
mAdb experiment ID: 38562

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC008
Sample_Description: subgroup B


title: HCC003_Cy5

description:
mAdb experiment ID: 44076

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC003
Sample_Description: subgroup B


title: HCC003_Cy3

description:
mAdb experiment ID: 44077

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC003
Sample_Description: subgroup B


title: HCC001_Cy5

description:
mAdb experiment ID: 44070

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC001
Sample_Description: subgroup B


title: Myc/Tgfa-08_Cy3

description:
mAdb experiment ID: 32264
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-08


title: Myc/Tgfa-09_Cy5

description:
mAdb experiment ID: 32266
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-09


title: HCC002_Cy5

description:
mAdb experiment ID: 44072

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC002
Sample_Description: subgroup A


title: HCC002_Cy3

description:
mAdb experiment ID: 44073

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC002
Sample_Description: subgroup A


title: Myc/Tgfa-07_Cy5

description:
mAdb experiment ID: 32262
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-07


title: Myc/Tgfa-10_Cy5

description:
mAdb experiment ID: 32267
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-10


title: Myc/Tgfa-01_Cy5

description:
mAdb experiment ID: 32253
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-01


title: Myc/Tgfa-05_Cy5

description:
mAdb experiment ID: 32258
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-05


title: Myc/Tgfa-05_Cy3

description:
mAdb experiment ID: 32257
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-05


title: Myc/Tgfa-02_Cy3

description:
mAdb experiment ID: 32254
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-02


title: Myc/Tgfa-02_Cy5

description:
mAdb experiment ID: 32255
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-02


title: Myc/Tgfa-08_Cy5

description:
mAdb experiment ID: 32265
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-08


title: Myc/Tgfa-06_Cy3

description:
mAdb experiment ID: 32259
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-06